A Structural Snapshot of CYP2B4 in Complex with Paroxetine Provides Insights into Ligand Binding and Clusters of Conformational States

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2013-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.113.204776PMID 23633618PMCID PMC3684837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins

  2013cited by this paper
• X‐ray Crystal Structure of the Cytochrome P450 2B4 Active Site Mutant F297A in Complex with Clopidogrel: Insights into Compensatory Rearrangements of the Binding Pocket

  2013cited by this paper
• Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysis.

  2013cited by this paper
• Investigation by site‐directed mutagenesis of the role of cytochrome P450 2B4 non‐active‐site residues in protein–ligand interactions based on crystal structures of the ligand‐bound enzyme

  2012cited by this paper
• Plasticity of CYP2B enzymes: structural and solution biophysical methods.

  2012cited by this paper
• Structural Characterization of Human Cytochrome P450 2C19

  2012cited by this paper
• Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.

  2012cited by this paper
• Three clusters of conformational states in p450cam reveal a multistep pathway for closing of the substrate access channel.

  2011cited by this paper
• Adaptive Accelerated Molecular Dynamics (Ad-AMD) Revealing the Molecular Plasticity of P450cam

  2011cited by this paper
• Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity.

  2011cited by this paper
• Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)pyridine: Insight into Inhibitor Binding and Rearrangement of Active Site Side Chains

  2011cited by this paper
• The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.

  2011cited by this paper
• Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel .

  2010cited by this paper
• Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography*

  2010cited by this paper
• Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.

  2010cited by this paper
• Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning.

  2009cited by this paper
• CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

  2008cited by this paper
• Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4.

  2007cited by this paper
• Designing facial amphiphiles for the stabilization of integral membrane proteins.

  2007cited by this paper
• Crystal Structure of the Mycobacterium tuberculosis P450 CYP121-Fluconazole Complex Reveals New Azole Drug-P450 Binding Mode*

  2006cited by this paper
• Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole

  2006cited by this paper
• Solving structures of protein complexes by molecular replacement with Phaser

  2006cited by this paper
• Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.

  2006cited by this paper
• Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6

  2006cited by this paper
• Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes*

  2005cited by this paper
• Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

  2004cited by this paper
• Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution

  2004cited by this paper
• ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION

  2004cited by this paper
• Analysis of void volumes in proteins and application to stability of the p53 tumour suppressor protein.

  2004cited by this paper
• MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes

  2004cited by this paper
• An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution

  2003cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function.

  2001cited by this paper
• The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins.

  2001cited by this paper
• Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.

  2001cited by this paper
• CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

  2000cited by this paper
• Functional interaction between amino-acid residues 242 and 290 in cytochromes P-450 2B1 and 2B11.

  1997cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Reassessment of cytochrome P450 2B2: catalytic specificity and identification of four active site residues.

  1997cited by this paper
• Alanine-scanning Mutagenesis of a Putative Substrate Recognition Site in Human Cytochrome P450 3A4

  1997cited by this paper
• Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.

  1996cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

  1994cited by this paper
• Detection, delineation, measurement and display of cavities in macromolecular structures.

  1994cited by this paper
• Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression.

  1993cited by this paper
• Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites

  1989cited by this paper
• Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems

  1975cited by this paper
• Cytochrome P-450 difference spectra: effect of chemical structure on type II spectra in mouse hepatic microsomes.

  1974cited by this paper
• Drug interaction with hepatic microsomal cytochrome.

  1966cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

  1964cited by this paper
• Biological Crystallography Integration of Macromolecular Diffraction Data

  year unknowncited by this paper
• Biological Crystallography New Paradigm for Macromolecular Crystallography Experiments at Ssrl: Automated Crystal Screening and Remote Data Collection

  year unknowncited by this paper

• Global transcriptome modulation by xenobiotics: the role of alternative splicing in adaptive responses to chemical exposures

  2024cites this paper
• Advancing insights on β-cyclodextrin inclusion complexes with SSRIs through lens of X-ray diffraction and DFT calculation

  2021cites this paper
• Paroxetine—Overview of the Molecular Mechanisms of Action

  2021influential citation
• Dissecting the Structural Plasticity and Dynamics of Cytochrome P450 2B4 by Molecular Dynamics Simulations

  2020cites this paper
• Interaction of drugs amlodipine and paroxetine with the metabolizing enzyme CYP2B4: a molecular dynamics simulation study

  2018influential citation
• Chapter 2 Fifty Years of Progress in Drug Metabolism and Toxicology : What Do We Still Need to Know About Cytochrome P 450 Enzymes ?

  2018cites this paper
• Structure-Function Analysis of Mammalian CYP 2 B Enzymes Using 7-Substituted Coumarin Derivatives as Probes : Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism s

  2016cites this paper
• Effect of detergent binding on cytochrome P450 2B4 structure as analyzed by X-ray crystallography and deuterium-exchange mass spectrometry.

  2016cites this paper
• Ordered chimerogenesis applied to CYP2B P450 enzymes.

  2016cites this paper
• Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives as Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism

  2016cites this paper
• Coumarin Derivatives as Substrate Probes of Mammalian Cytochromes P450 2B4 and 2B6: Assessing the Importance of 7-Alkoxy Chain Length, Halogen Substitution, and Non-Active Site Mutations.

  2016cites this paper
• Insights into the Role of Substrates on the Interaction between Cytochrome b5 and Cytochrome P450 2B4 by NMR

  2015cites this paper
• Analysis of Cytochrome P450 CYP119 Ligand-dependent Conformational Dynamics by Two-dimensional NMR and X-ray Crystallography*

  2015influential citation
• Functional importance of a peripheral pocket in mammalian cytochrome P450 2B enzymes.

  2015cites this paper
• Structural and Biophysical Characterization of Human Cytochromes P450 2B6 and 2A6 Bound to Volatile Hydrocarbons: Analysis and Comparison

  2015cites this paper
• Fifty Years of Progress in Drug Metabolism and Toxicology: What Do We Still Need to Know About Cytochrome P450 Enzymes?

  2014cites this paper